BridgeBio Oncology Therapeutics

Price & Volume

Track all markets on TradingView

Stats

See more
Open
$7.80
Previous Close
$7.66
Day Range
$7.70-$8.22
52W Range
$7.60-$14.87
Market Cap
$613.6M
Shares Short
3M

Financials

See more
Revenue (12 Mos)
$0
Revenue Growth (YoY)
0%
Gross Profit (12 Mos)
$0
Diluted EPS
-$4.30

News

See more

Yahoo Finance • 8 hours ago

Here Are Monday’s Top Wall Street Analyst Research Calls: Dell Technologies, BioMarin Pharmaceutical, Disney, HubSpot, Klarna, Oklo, Pitney Bowes, Trade Desk, Wendy’s, and More

Yahoo Finance • 19 days ago

BridgeBio Reports Promising Preclinical Data For BBO-10203 In HER2 Cancer Cell Lines

Yahoo Finance • 20 days ago

BBOT Presents Preclinical Data Showing RAS:PI3Kα Breaker BBO-10203 Inhibits PI3Kα/AKT Signaling in HER2AMP Models at the AACR Annual Meeting 2026

Yahoo Finance • 21 days ago

BBOT Granted U.S. FDA Fast Track Designation for BBO-11818 for the Treatment of Adult Patients with Advanced KRAS-Mutant Pancreatic Ductal Adenocarcinoma

About

Address
256 East Grand Avenue, South San Francisco, CA, United States, 94080
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
92